These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2837300)

  • 1. Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis.
    Oldenburg B; MacDonald GJ; Shelley S
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1089-91. PubMed ID: 2837300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dual blockade of the renin-angiotensin system on thirst in hemodialysis patients.
    Masajtis-Zagajewska A; Nowicki M
    Nephron Clin Pract; 2009; 112(4):c242-7. PubMed ID: 19546583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of thirst in end-stage kidney insufficiency].
    Heidbreder E; Bahner U; Hess M; Geiger H; Götz R; Kirsten R; Rascher W; Heidland A
    Klin Wochenschr; 1990 Nov; 68(22):1127-33. PubMed ID: 2149156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure.
    Yamamoto T; Shimizu M; Morioka M; Kitano M; Wakabayashi H; Aizawa N
    JAMA; 1986 Aug; 256(5):604-8. PubMed ID: 3522948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of long-term use of angiotensin-converting enzyme inhibitors by hemodialysis patients on thirst and fluid weight gain.
    Hamad A; Khosrovaneh A; Gupta S; Fazal S; Manis T; Feinfeld DA
    Ren Fail; 2002 Jul; 24(4):461-6. PubMed ID: 12212825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction in hypertensive man between sodium intake, converting enzyme inhibitor (enalapril), plasma renin and blood pressure control.
    Morgan T; Anderson A
    J Hum Hypertens; 1988 Mar; 1(4):311-5. PubMed ID: 2851654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in cough reflex after treatment with enalapril and ramipril.
    McEwan JR; Choudry N; Street R; Fuller RW
    BMJ; 1989 Jul; 299(6690):13-6. PubMed ID: 2547470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA; Calzada C; Ballesteros A; Amato D
    Rev Invest Clin; 2012; 64(4):315-21. PubMed ID: 23227581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of enalapril in congestive cardiac failure.
    McGrath BP; Arnolda L; Matthews PG; Jackson B; Jennings G; Kiat H; Johnston CI
    Br Heart J; 1985 Oct; 54(4):405-14. PubMed ID: 2996575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
    MacGregor GA; Markandu ND; Bayliss J; Roulston JE; Squires M; Morton JJ
    Br Med J (Clin Res Ed); 1981 Aug; 283(6288):401-3. PubMed ID: 6266576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting-enzyme inhibition abolishes polydipsia induced by dietary NaCl and K depletion.
    McKay AJ; Poirier CD; Peterson LN
    Am J Physiol; 1990 May; 258(5 Pt 2):F1164-72. PubMed ID: 2337148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual blockade of the renin-angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration.
    Zwiech R; Bruzda-Zwiech A
    Int Urol Nephrol; 2013 Oct; 45(5):1365-72. PubMed ID: 23136031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics.
    Naranjo CA; Kadlec KE; Sanhueza P; Woodley-Remus D; Sellers EM
    Clin Pharmacol Ther; 1991 Jul; 50(1):96-106. PubMed ID: 1855357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
    Barnett A
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S132-5. PubMed ID: 16565237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of arterial hypertension in the aged subject with a converting enzyme inhibitor: enalapril].
    Forette F; Handfield-Jones R; Henry-Amar M; Fouchard M; Bouchacourt P; Hervy MP; Henry JF; Mesguisch-Billaud E; Alexandre JM
    Presse Med; 1985 Dec; 14(44):2237-41. PubMed ID: 3003729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.